TY - THES A1 - Brasche, Juliane T1 - Patienten- und Anwenderfreundlichkeit des Safeguard-Druckverbandes im Vergleich zum ET-Druckverband (Nürnberger Ufo) zur Blutstillung nach transfemoralem Zugang : Studie T1 - Patient comfort and user convenience of pressure bandaging after femoral catheterization: A comparison between Safeguard and ET (Nürnberger UFO) pressure dressing N2 - Ziel der Arbeit war der Vergleich von zwei Druckverbandsystemen in Hinblick auf effektive Blutstillung, Patienten- sowie Anwenderfreundlichkeit. Dazu wurden 117 Patienten, die sich zwischen März 2011 und Dezember 2012 im Klinikum Fulda einer diagnostischen Angiographie unterzogen, in einer randomisierten offenen klinisch kontrollierten Studie untersucht. Die in der Studie untersuchten Druckverbände stellten sich als gleich sicher und effektiv bei der Blutstillung heraus. Es traten in der gesamten Studienpopulation keine schwergradigen Komplikationen auf. Der Safeguard-Druckverband lässt sich leichter und schneller anbringen und entfernen, als der mit elastischen Binden fixierte ET-Druckverband. Er wurde zudem durch die Patienten besser toleriert und als bequemer empfunden. Zusammenfassend ist der Safeguard-Druckverband nach unkomplizierten diagnostischen Angiographien ebenso sicher, wie der UFO-Druckverband und zeigte darüber hinaus eine höhere Anwender- und Patientenfreundlichkeit. N2 - The aim of this study was the comparison of two types of pressure bandaging with regard to effective hemostasis, patient comfort and user convenience. One hundred and seventeen patients undergoing diagnostic angiography utilizing femoral artery access were examined in a randomized, single center, open, controlled, clinical trial. Both pressure bandages were equally safe and effective in achieving hemostasis. No major complications were observed. The Safeguard pressure dressing was significantly easier and faster to place and to remove than the ET pressure dressing with elastic bandages. Patients also evaluated the Safeguard pressure dressing as significantly more comfortable and tolerable. The study demonstrates that the Safeguard pressure dressing is equally safe as the ET pressure dressing after uncomplicated diagnostic angiography and results in improved patient comfort and user convenience. KW - Druckverband KW - Blutstillung KW - Studie KW - Studie KW - study KW - Vergleich KW - Druckverbände KW - Patientenfreundlichkeit KW - Anwenderfreundlichkeit KW - comparison KW - pressure bandages KW - patient comfort KW - user convenience Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-180921 ER - TY - JOUR A1 - Boch, Tobias A1 - Spiess, Birgit A1 - Heinz, Werner A1 - Cornely, Oliver A. A1 - Schwerdtfeger, Rainer A1 - Hahn, Joachim A1 - Krause, Stefan W. A1 - Duerken, Matthias A1 - Bertz, Hartmut A1 - Reuter, Stefan A1 - Kiehl, Michael A1 - Claus, Bernd A1 - Deckert, Peter Markus A1 - Hofmann, Wolf‐Karsten A1 - Buchheidt, Dieter A1 - Reinwald, Mark T1 - Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis JF - Mycoses N2 - Invasive aspergillosis (IA) is a severe complication in immunocompromised patients. Early diagnosis is crucial to decrease its high mortality, yet the diagnostic gold standard (histopathology and culture) is time‐consuming and cannot offer early confirmation of IA. Detection of IA by polymerase chain reaction (PCR) shows promising potential. Various studies have analysed its diagnostic performance in different clinical settings, especially addressing optimal specimen selection. However, direct comparison of different types of specimens in individual patients though essential, is rarely reported. We systematically assessed the diagnostic performance of an Aspergillus‐specific nested PCR by investigating specimens from the site of infection and comparing it with concurrent blood samples in individual patients (pts) with IA. In a retrospective multicenter analysis PCR was performed on clinical specimens (n = 138) of immunocompromised high‐risk pts (n = 133) from the site of infection together with concurrent blood samples. 38 pts were classified as proven/probable, 67 as possible and 28 as no IA according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group consensus definitions. A considerably superior performance of PCR from the site of infection was observed particularly in pts during antifungal prophylaxis (AFP)/antifungal therapy (AFT). Besides a specificity of 85%, sensitivity varied markedly in BAL (64%), CSF (100%), tissue samples (67%) as opposed to concurrent blood samples (8%). Our results further emphasise the need for investigating clinical samples from the site of infection in case of suspected IA to further establish or rule out the diagnosis. KW - antifungal KW - aspergillosis KW - BAL KW - blood KW - cerebrospinal fluid KW - comparison KW - PCR KW - Aspergillus Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-214065 VL - 62 IS - 11 SP - 1035 EP - 1042 ER -